|
Real-time
OTC Markets
01:29:53 05/06/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.2050 USD | +0.49% |
|
+28.41% | -10.38% |
Evolution of the Average Target: Northwest Biotherapeutics, Inc.
Evolution of the Target Price: Northwest Biotherapeutics, Inc.
Changes in Analyst Recommendations: Northwest Biotherapeutics, Inc.
a3cc1f1f26b9.y8i2sTFtfUmMmC4L7crguDaGb6EecFc_8IUI8G4HExA.mr-H3QMhGgDF8Vg6obOI3FjHJ_d1FAB7m9FxvRpRWkGzpNzkRDIEZP6tXQ~20f365ce9243e36f136b8c735df85338
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +571.59% | |||
| +11.79% | |||||
| +21.92% | |||||
| +19.64% | |||||
| +7.4% | |||||
| +25.43% | |||||
| +18.27% | |||||
| +50.7% | |||||
| +3.91% | |||||
| +73.24% | |||||
| Average | +80.39% | |||||
| Weighted average by Cap. | +22.55% |
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1489USD
Average target price
1.000USD
Spread / Average Target
+571.59%
High Price Target
1.000USD
Spread / Highest target
+571.59%
Low Price Target
1.000USD
Spread / Lowest Target
+571.59%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- NWBO Stock
- Consensus Northwest Biotherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
